Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides
- 30 July 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 66 (5), 819-830
- https://doi.org/10.1016/s0006-2952(03)00407-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?The Oncologist, 2002
- Receptor tyrosine kinases as targets for anticancer drugsTrends in Molecular Medicine, 2002
- Nuclear localization of EGF receptor and its potential new role as a transcription factorNature Cell Biology, 2001
- Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivoNucleic Acids Research, 2001
- The cellular delivery of antisense oligonucleotides and ribozymesDrug Discovery Today, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Antisense Technology: Selection and Delivery of Optimally Acting Antisense OligonucleotidesJournal of Drug Targeting, 1998
- Mapping of RNA accessible sites for antisense experiments with oligonucleotide librariesNature Biotechnology, 1998
- Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C- raf kinase supports an antisense mechanism of action in vivoProceedings of the National Academy of Sciences, 1996
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996